The efficacy of postoperative bridging with dalteparin vs placebo was evaluated in those with AF or mechanical heart valves when warfarin is temporarily interrupted for a surgical procedure.
Investigators report findings from the ACTION trial assessing outcomes of therapeutic vs prophylactic oral anticoagulant use among hospitalized adult patients with COVID-19 and elevated D-dimer concentration.
The longitudinal, prospective study assessed whether an association existed between MI with a silent manifestation and the occurrence of subsequent ischemic stroke.
The first oral blood thinning medication for children was approved by the US Food and Drug Administration, the agency announced Monday.
The researchers’ goal was to determine the clinical impact of stent graft thrombosis and its prognosis.
The researchers addressed whether ziltivekimab safely and effectively reduced biomarkers of inflammation and thrombosis among patients with high cardiovascular risk and chronic kidney disease.
Researchers conducted a review of patients who were tested for COVID-19 and received aspirin or NSAIDS to assess whether aspirin was protective from death, myocardial infarction, or VTE.
The researchers sought to identify major interaction effects between clopidogrel and CYP2C19*17 status, in terms of risk for MACE and bleeding events after PCI.
CVST with thrombocytopenia reported after COVID-19 vaccine with adenoviral vector; management similar to heparin-induced thrombocytopenia.
The objective of this study was to test the efficacy and safety of revacept, a novel, lesion-directed antithrombotic drug, acting as a competitive antagonist to platelet glycoprotein VI.